Skip to main content

Find Clinical Trials

Home
Conditions
Sepsis

Clinical trial condition

Sepsis

Explore clinical trials studying Sepsis. Study availability and eligibility vary by location and protocol.

1,569 public trials 231 recruiting studies

Refine in advanced search Browse all conditions

Sepsis trial results

Completed

Prevention of Catheter-Associated Infection With the Skin Disinfectant Octenidine Dihydrochloride

NCT00515151

Conditions: Bacteremia, Bacterial Infections, Bacterial Infections and Mycoses, +9 more
Locations: Institute of Environmental Medicine and Hospital Epidemiology University Medical Center Freiburg Freiburg im Breisgau, Germany

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel Basel, Switzerland

View Trial Details

Completed

Investigation of Correlation Between Interstitial and Arterial Blood Glucose Concentrations in Septic Patients

NCT00463645

Conditions: Infections, Inflammation, Pathologic Processes, +4 more
Locations: Medical University Graz Graz, Styria, Austria

View Trial Details

Completed

Phenylephrine Versus Norepinephrine in Septic Shock

NCT00481442

Conditions: Infections, Inflammation, Pathologic Processes, +6 more
Locations: Department of Anesthesiology and Intensive care of the University of Rome "La Sapienza" Rome, Italy

View Trial Details

Completed

Effects of Alkaline Phosphatase on Renal Function in Septic Patients

NCT00457613

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +16 more
Locations: Radboud University Medical Centre Nijmegen, Gelderland, Netherlands

View Trial Details

Completed

A Trial of Heparin in Patients With Severe Sepsis Who Are Undergoing Treatment With Drotrecogin Alfa (Activated)

NCT00049777

Conditions: Infections, Inflammation, Pathologic Processes, +3 more
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician Berlin, Germany

View Trial Details

Completed

Super High-Flux - High Volume Dialysis in Sepsis-Induced Acute Renal Failure

NCT00333593

Conditions: Acute Kidney Injury, Acute Renal Failure, Female Urogenital Diseases, +12 more
Locations: Austin Hospital Melbourne, Victoria, Australia

View Trial Details

Completed

Comparison of Pediatric Septic Shock Treatment With and Without Central Venous Oxygen Saturation Monitoring

NCT00407823

Conditions: Infections, Inflammation, Pathologic Processes, +7 more
Locations: Instituto da Criança - HC-FMUSP São Paulo, Brazil

Hospital Universitário - USP São Paulo, Brazil

View Trial Details

Completed

Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe Sepsis

NCT00406198

Conditions: Bacteremia, Bacterial Infections, Bacterial Infections and Mycoses, +16 more
Locations: Lariboisiere University Hospital Paris, France

View Trial Details

Completed

The Study of Drotrecogin Alfa (Activated) in a Subpopulation of Adult Patients With Severe Sepsis

NCT00045760

Conditions: Infections, Inflammation, Pathologic Processes, +3 more
Locations: For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Mobile, Alabama, United States

For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Phoenix, Arizona, United States

For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Scottsdale, Arizona, United States

For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Tuscon, Arizona, United States

View all 426 locations

View Trial Details

Completed

A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis

NCT00034476

Conditions: Infections, Inflammation, Pathologic Processes, +3 more
Locations: Birmingham, Alabama, United States

Phoenix, Arizona, United States

Berkeley, California, United States

Los Angeles, California, United States

View all 85 locations

View Trial Details